AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer

Colorectal cancer is a common malignancy with the third highest incidence and second highest mortality rate among all cancers in the world. Chemotherapy resistance in colorectal cancer is an essential factor leading to the high mortality rate. The ATP-binding cassette (ABC) superfamily G member 2 (A...

Full description

Bibliographic Details
Main Authors:	Kun Liu, Yan-Chi Li, Yu Chen, Xiao-Bao Shi, Zi-Hao Xing, Zheng-Jie He, Sheng-Te Wang, Wei-Jing Liu, Peng-Wei Zhang, Ze-Zhong Yu, Xue-Mei Mo, Mei-Wan Chen, Zhe-Sheng Chen, Zhi Shi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Oncology
Subjects:	AZ32 ABCG2 multidrug resistance colorectal cancer CRISPR
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.680663/full

Similar Items

Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor
by: Jing-Quan Wang, et al.
Published: (2020-12-01)

Posttranscriptional Regulation of the Human ABCG2 Multidrug Transporter Protein by Artificial Mirtrons
by: Anita Schamberger, et al.
Published: (2021-07-01)

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells
by: Zhuo-Xun Wu, et al.
Published: (2020-05-01)

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
by: Yongchao Zhang, et al.
Published: (2020-11-01)

Cellular Processing of the ABCG2 Transporter—Potential Effects on Gout and Drug Metabolism
by: Orsolya Mózner, et al.
Published: (2019-10-01)

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor
by: Zhuo-Xun Wu, et al.
Published: (2021-07-01)

Effects of High-Intensity Resistance Training and Aerobic Exercise on Expression of ABCG4, ABCG5 and ABCG8 Genes in Female Athletes
by: Reza Bagheri, et al.
Published: (2020-05-01)

BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
by: Yunali V. Ashar, et al.
Published: (2020-09-01)

Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo
by: Fanpu Zeng, et al.
Published: (2020-05-01)

Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells
by: Pranav Gupta, et al.
Published: (2018-02-01)

Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo
by: Xiaoran Guo, et al.
Published: (2018-02-01)

Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat
by: Chung-Pu Wu, et al.
Published: (2021-03-01)

A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells
by: Chao Guo, et al.
Published: (2018-12-01)

Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 gene
by: Hayato Tada, et al.
Published: (2020-01-01)

Cooperative transcriptional activation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 genes by nuclear receptors including Liver-X-Receptor
by: Su Sun Back, et al.
Published: (2013-06-01)

Evaluation of mRNA Expression Profile of ABCG2/BCRP in Childhood Acute Lymphoblastic Leukemia
by: M Entezar-e-Ghaem, et al.
Published: (2013-12-01)

Analysis of Sequence Divergence in Mammalian ABCGs Predicts a Structural Network of Residues That Underlies Functional Divergence
by: James I. Mitchell-White, et al.
Published: (2021-03-01)

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance
by: Zhuo-Xun Wu, et al.
Published: (2020-01-01)

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
by: Yi-Dong Li, et al.
Published: (2020-06-01)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
by: Wei Zhang, et al.
Published: (2018-10-01)

Effect of physical activity on prevention and treatment of atherosclerosis: focus on activity of ABCG5 and ABCG8 genes
by: Mohsen Jafari
Published: (2019-10-01)

Induction of Liver Abcg5/Abcg8 Expression is an Important Determinant of the Macrophage-to-Feces Reverse Cholesterol Transport Response to Treatment with Ezetimibe
by: Altemus, Jessica B.
Published: (2013)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
by: Ning Ji, et al.
Published: (2018-10-01)

The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and its Targets, ABCG1 and ABCG4
by: Amjad Alrosan, et al.
Published: (2019-06-01)

Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells
by: Jingqiu Wang, et al.
Published: (2020-02-01)

ABCG2 Overexpression Contributes to Pevonedistat Resistance
by: Rishil J. Kathawala, et al.
Published: (2020-02-01)

Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line
by: Zhuo-Xun Wu, et al.
Published: (2021-02-01)

Cariprazine, A Dopamine D2/D3 Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer
by: Noor Hussein, et al.
Published: (2018-09-01)

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
by: Xiao Fu, et al.
Published: (2018-03-01)

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
by: Yuqi Yang, et al.
Published: (2021-02-01)

High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma
by: Hao Shu, et al.
Published: (2021-01-01)

Impact of Q141K on the Transport of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by ABCG2
by: Yutaka Inoue, et al.
Published: (2019-07-01)

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP
by: Sophie E. B. Ambjørner, et al.
Published: (2020-03-01)

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
by: Jing-Quan Wang, et al.
Published: (2020-02-01)

Conception et développement de nouveaux ligands des transporteurs ABCG2 et MRP1 dans le cadre de la résistance à de multiples drogues anticancéreuses.
by: Lecerf - Schmidt, Florine
Published: (2015)

Transmembrane Polar Relay Drives the Allosteric Regulation for ABCG5/G8 Sterol Transporter
by: Bala M. Xavier, et al.
Published: (2020-11-01)

Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells
by: Yuri Namba, et al.
Published: (2018-10-01)

Structure-Function Relationship of the Sterol Transporter ABCG5/G8: Expression, Purification and Enzymatic Characterization of ABCG5/G8 Missense Loss of Function Mutations
by: Zein, Aiman
Published: (2020)

Expression of ABCG2 (BCRP) in mouse models with enhanced erythropoiesis
by: Gladys Oluyemisi Latunde-Dada, et al.
Published: (2014-06-01)

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro
by: Yuqi Yang, et al.
Published: (2020-05-01)